• home
  • search
  • contact
About Us
  • Corporate Overview
  • board of directors
  • scientific advisory board

Our molecular imaging agents are targeted to the pathological changes underlying chronic human diseases.

Board of Directors

Peter S. Conti, M.D., Ph.D., FACR, FACNP - Director

Dr. Conti has served as the Company’s Medical Director and Director of the Company since October 2004. Dr. Conti is a Professor of Radiology, Pharmacy, and Biomedical Engineering at the University of Southern California as well as Director of its Positron Imaging Science Center and Clinic. Dr. Conti received his medical degree from Cornell University and completed his residency in Diagnostic Radiology and fellowship in Nuclear Medicine at The Johns Hopkins Medical Institution. He is board-certified in both Diagnostic Radiology and Nuclear Medicine. Dr. Conti currently serves on the Board of Directors and is a past-president of the Society of Nuclear Medicine (SNM). He also serves on a number of committees for the SNM that are focused on the development of the PET technology and its applications in medicine, including those involving government and regulatory affairs.